☰ Navigation Tabs
Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions.
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-1H TOCSY 2.5 - 3.0 mM insulin, residues 90-110, 2.5 - 3.0 mM insulin, residues 25-54, 73 % H2O, 27 % CD3CN H2O / CD3CN 1 2.5 ambient 298 2 2D 1H-1H NOESY 2.5 - 3.0 mM insulin, residues 90-110, 2.5 - 3.0 mM insulin, residues 25-54, 73 % H2O, 27 % CD3CN H2O / CD3CN 1 2.5 ambient 298 3 2D 1H-1H NOESY 2.5 - 3.0 mM insulin, residues 90-110, 2.5 - 3.0 mM insulin, residues 25-54, 73 % D2O-7, 27 % CD3CN-8 D2O / CD3CN 1 2.5 ambient 298 4 2D 1H-13C HSQC 2.5 - 3.0 mM insulin, residues 90-110, 2.5 - 3.0 mM insulin, residues 25-54, 73 % D2O-7, 27 % CD3CN-8 D2O / CD3CN 1 2.5 ambient 298
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Varian Uniform NMR System 500
NMR Refinement Method Details Software torsion angle dynamics, DGSA-distance geometry simulated annealing Amber
NMR Ensemble Information Conformer Selection Criteria structures with the lowest energy Conformers Calculated Total Number 100 Conformers Submitted Total Number 20 Representative Model 1 (fewest violations)
Computation: NMR Software # Classification Version Software Name Author 1 refinement Amber 11 Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, and Kollman 2 structure solution Amber 11 Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, and Kollman 3 refinement CYANA 2.1 Guntert, Mumenthaler and Wuthrich 4 collection VnmrJ 2.2 C Varian 5 chemical shift assignment Sparky 2.6 Goddard